ATE395062T1 - Kombination von opioiden und einem piperazin- derivat für die behandlung von schmerzen - Google Patents

Kombination von opioiden und einem piperazin- derivat für die behandlung von schmerzen

Info

Publication number
ATE395062T1
ATE395062T1 AT04741745T AT04741745T ATE395062T1 AT E395062 T1 ATE395062 T1 AT E395062T1 AT 04741745 T AT04741745 T AT 04741745T AT 04741745 T AT04741745 T AT 04741745T AT E395062 T1 ATE395062 T1 AT E395062T1
Authority
AT
Austria
Prior art keywords
opioids
pain
treatment
combination
piperazine derivative
Prior art date
Application number
AT04741745T
Other languages
English (en)
Inventor
Frans Eduard Janssens
Francois Maria Sommen
Joseph E Leenaerts
Roosbroeck Y E M Van
Theo Frans Meert
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33547554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE395062(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE395062T1 publication Critical patent/ATE395062T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT04741745T 2003-06-10 2004-06-07 Kombination von opioiden und einem piperazin- derivat für die behandlung von schmerzen ATE395062T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP0306118 2003-06-10

Publications (1)

Publication Number Publication Date
ATE395062T1 true ATE395062T1 (de) 2008-05-15

Family

ID=33547554

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04741745T ATE395062T1 (de) 2003-06-10 2004-06-07 Kombination von opioiden und einem piperazin- derivat für die behandlung von schmerzen

Country Status (9)

Country Link
US (1) US20080070924A1 (de)
AR (1) AR044491A1 (de)
AT (1) ATE395062T1 (de)
CL (1) CL2004001422A1 (de)
DE (1) DE602004013772D1 (de)
ES (1) ES2307025T3 (de)
MY (1) MY137858A (de)
TW (1) TW200510371A (de)
WO (1) WO2004110451A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2431524T3 (es) 2004-04-13 2013-11-26 Incyte Corporation Derivados de piperazinilpiperidina como antagonistas de los receptores de quimiocinas
WO2006074025A1 (en) 2004-12-30 2006-07-13 Janssen Pharmaceutica N.V. Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
NZ556628A (en) 2005-03-08 2009-09-25 Janssen Pharmaceutica Nv Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists
WO2010081851A1 (en) 2009-01-14 2010-07-22 Genoscience Pharma Piperidin-4-ylpiperazine compounds for the treatment of hcv infection
AU2010239188B2 (en) * 2009-04-22 2016-03-31 Janssen Pharmaceutica Nv Azetidinyl diamides as monoacylglycerol lipase inhibitors
WO2011037771A1 (en) * 2009-09-23 2011-03-31 Merck Sharp & Dohme Corp. Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
UA108233C2 (uk) 2010-05-03 2015-04-10 Модулятори активності гідролази амідів жирних кислот
CN108902893B (zh) 2013-02-08 2022-02-25 通用磨坊公司 低钠食品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2287404A (en) * 1994-03-15 1995-09-20 Pfizer Antiinflammatory and analgesic compositions
GB9426102D0 (en) * 1994-12-23 1995-02-22 Merck Sharp & Dohme Pharmacuetical compositions
NZ321575A (en) * 1995-10-30 1999-05-28 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives
GB9723544D0 (en) * 1997-11-07 1998-01-07 Merck Sharp & Dohme Therapeutic agents
GB9904786D0 (en) * 1999-03-02 1999-04-28 Merck Sharp & Dohme Therapeutic agents
US6759520B1 (en) * 1999-10-28 2004-07-06 The New England Medical Center Hospitals, Inc. Chimeric analgesic peptides
GB0025354D0 (en) * 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
GB0203022D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
ES2307025T3 (es) 2008-11-16
US20080070924A1 (en) 2008-03-20
AR044491A1 (es) 2005-09-14
DE602004013772D1 (de) 2008-06-26
CL2004001422A1 (es) 2005-05-27
MY137858A (en) 2009-03-31
WO2004110451A1 (en) 2004-12-23
TW200510371A (en) 2005-03-16

Similar Documents

Publication Publication Date Title
ATE374196T1 (de) Dihydrobenzodiazepin-2-on-derivative für die behandlung von neurologischen erkrankungen
ATE441417T1 (de) Benzoädüazepinderivate für die behandlung von neurologischen krankheiten
ATE440866T1 (de) Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten
ATE369133T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
EP1687733A4 (de) System und prozess zur ermöglichung der bereitstellung von gesundheitsversorgung
EP1626730A4 (de) Verfahren, gerät und zusammensetzung zur behandlung von akne
PT1615909E (pt) Derivados de piperazina e a sua utilização para o tratamento de doenças neurológicas e psiquiátricas
DE60322451D1 (de) 4-Tetrazolyl-4-Phenylpiperidinderivate zur Schmerzbehandlung
ATE502642T1 (de) Kombinationen für die behandlung von immun- entzündlichen erkrankungen
EP1701664A4 (de) System und verfahren zur behandlung von gewebe
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE602004019576D1 (de) Zur behandlung von schmerzen geeignete piperazine
CY2013031I1 (el) Χρηση διϋδροϊμιδαζολονων για την αγωγη της επιληψιας στους σκυλους
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
DE602004013772D1 (de) Kombination von opioiden und einem piperazin-derivat für die behandlung von schmerzen
EP1791423A4 (de) Zusammensetzungen und verfahren für die behandlung von hyperproliferativen hautkrankheiten
DE60315490D1 (de) Therapeutische behandlung
DE60305400D1 (de) Anlage zur Behandlung von Produkten und dazugehörige Datenerfassungseinheit
DE602004011275D1 (de) Zusammensetzungen und Verfahren zur Behandlung von Fettleibigkeit
ATE272619T1 (de) Anilin-disulfid-derivate zur behandlung allergischer erkrankungen
DE602004026067D1 (de) Gerät zur Behandlung von Füßen
ATE482707T1 (de) 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen
ATE391507T1 (de) S-methyl-dihydro-ziprasidone für die behandlung von schizophrenie
DE502004008837D1 (de) Bengamide-derivate und deren verwendung zur behandlung von krebserkrankungen
DE60308390D1 (de) Behandlung von Hyperurikämie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties